Remuneration Information • Mar 22, 2024
Remuneration Information
Open in ViewerOpens in native device viewer
The remuneration policy of the company applicable to the fiscal year 2023 and approved by the General Meeting of 26 April 2023 is published on the website of the company.
In accordance with the applicable policy, in 2023 the non-executive directors received only fixed basic remuneration for their membership or chairmanship of the Board of Directors, plus fixed remuneration for their membership or chairmanship of any advisory committees. The remuneration policy enabled the company to safeguard the necessary competence and experience on the Board of Directors.
| Name, Position | Basic remuneration |
Remuneration as a member of the Audit and Risk Committee |
Remuneration as a mem ber of the Nomination and Remuneration Committee |
Total remuneration |
|---|---|---|---|---|
| Herman Van de Velde NV, always represented by Herman Van de Velde (Chairman) |
40,000 € | 0 € | 7,500 € | 47,500 € |
| YJC BV, always represented by Yvan Jansen (Independent director) |
20,000 € | 5,000 € | 5,000 € | 30,000 € |
| Valseba BV, always represented by Isabelle Maes (Independent director) |
20,000 € | 7,500 € | 5,000 € | 32,500 € |
| Fidigo NV(1), always represented by Dirk Goeminne (Independent director) |
20,000 € | 5,000 € | 0 € | 8,333 € |
| Executive NV(2), always represented by Dirk Goeminne (Independent director) |
20,000 € | 5,000 € | 0 € | 16,667 € |
| Lucas Laureys(1) | 20,000 € | 5,000 € | 0 € | 8,333 € |
| Benedicte Laureys | 20,000 € | 0 € | 0 € | 20,000 € |
| Veronique Laureys | 20,000 € | 5,000 € | 0 € | 25,000 € |
| Greet Van de Velde | 20,000 € | 0 € | 0 € | 20,000 € |
| Mavac BV, always represented by Marleen Vaesen | 20,000 € | 0 € | 0 € | 20,000 € |
| BVHX BV(2), always represented by Bruno Vanhoorickx (Independent director) |
20,000 € | 0 € | 0 € | 13,333 € |
| PARCinvest BV(2), always represented by Christian Salez |
20,000 € | 0 € | 0 € | 13,333 € |
(1) Pro rata from 01.01.2023 up to and including 26.04.2023.
(2) Pro rata from 27.04.2023 up to and including 31.12.2023.
In 2023 the executive management was entrusted to the Management Team, which is chaired by the CEO. In accordance with the applicable remuneration policy, the following remuneration was awarded to the members of the Management Committee and the Management Team:
| 1. Fixed remuneration |
2. Variable remuneration |
5. | 6. Fixed/ |
|||||
|---|---|---|---|---|---|---|---|---|
| Name, Position | Basic remuneration |
Additional benefits (1) |
One year variable |
Multi-year variable |
3. Exceptional items |
4. Pension Cost (2) |
Total remunera tion |
veriable remuneration ratio |
| Karel Verlinde CommV (CEO), always repre |
87% fixed remuneration |
|||||||
| sented by Karel Verlinde (management company) |
360,000 € | 0 € | 55,008 € | 0 € | 0 € | 0 € | 415,008 € | 13% variable remuneration |
| Other members of the Management Team |
Between 80% and 100% fixed remuneration |
|||||||
| together (excluding CEO)(3) |
1,230,392 € | 85,222 € | 95,823 € | 0 € | 0 € | 37,137 € | 1,448,574 € | Between 20% and 0% variable remuneration |
(1) Only applicable to the member of the Management Team who works on the basis of an employment contract.
Fixed reimbursement of expenses also includes meal vouchers, hospitalization insurance and company car.
(2) Only applicable to the member of the Management Team who works on the basis of an employment contract. (3) If remunerated through an employment contract, the social security charges paid by the employer are not included.
If remunerated through a management agreement, the total cost for the company is included.
As stated in the remuneration policy, the targets for short-term variable remuneration are based partly on objective parameters closely linked to the results of the Group (collective targets) and partly on individual targets closely linked to the responsibility of the member in question. The collective targets represent 80% of the total targets, the individual targets 20%. Three collective targets were set for 2023: turnover, EBITDA and one quality-related target. The Board of Directors, on the proposal of the Nomination and Remuneration Committee, established the turnover and EBITDA for 2023 and the extent to which the targets were achieved. On this basis, the corresponding payment level was established. The corresponding payment level of the collective targets combined is equal to 20 % of the collective target bonus.
| a) | Measured performance | ||
|---|---|---|---|
| Performance criteria (PC) |
Relative weight |
b) | Corresp. Payment level (*) |
| Turnover | 40% | a) | Below target |
| b) | 0.00% | ||
| EBITDA | 40% | a) | Below target |
| b) | 0.00% | ||
| 20% | a) | On target | |
| NPS (Retail partners) | b) | 20.00% |
The individual targets were set and evaluated for each individual Management Team member.
No long-term variable remuneration was granted in 2023.
Members of the executive management who have an employment contract participate in the company pension plan. This is a defined contribution pension plan to which the employer contributes 4% of the employee's fixed remuneration limited to the amount of the pension ceiling(1) and 5% of the annual salary exceeding the pension ceiling.
The non-executive directors do not receive any remuneration in the form of shares. This means the company departs from Recommendation 7.6 of the Corporate Governance Code 2020. This departure is explained by the fact that the family directors are, directly or indirectly, long-term shareholders of the company and, in general, the non-executive directors are currently deemed to be sufficiently focused on long-term value creation for the company. The award of the shares to the non-executive directors is deemed unnecessary for that reason. However, the company will evaluate this recommendation on a regular basis in regard to any (mandatory) compliance in the future.
No minimum threshold has been set for shares that must be held by the members of the executive management. This means the company departs from Recommendation 7.9 of the Corporate Governance Code 2020. This departure is explained by the fact that the interests of the executive management are currently deemed to be sufficiently oriented to long-term value creation in the company by means of an existing longterm incentive programme in the form of an option plan (see table on the right). Setting a minimum threshold for shares that must be held by the members of the executive management is deemed unnecessary for that reason. However, the company will evaluate this recommendation on a regular basis in regard to any (mandatory) compliance in the future.
The Board of Directors of 29 April 2020 approved the 2020 option plan. As a result, the Nomination and Remuneration Committee can award options on shares of the company to the executive management for five years. These options are awarded free of charge. The exercise price of the options is, per share, equal to the lowest amount of (i) the average of the closing prices of the share on the market over the thirty calendar days prior to the date of the offer or (ii) the closing price of the final trading day prior to the date of the offer. The options are valid for a term of ten years. The company and the option holder may decide by mutual agreement to reduce the term of validity of the options below ten years, but it can never be reduced below five years. The options are not exercisable before the end of the third calendar year following the year in which the options are offered.
(1) For 2023, 76,395.98 euro.
| Most important provisions of the share option plan |
||||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| Name, Position | Identification of the Plan |
Offer date | acquisition date |
|||
| 2015 | 15.10.2019 | 14.12.2019 | ||||
| Mavac BV | 2020 | 09.10.2020 | 08.12.2020 | |||
| 2020 | 01.10.2021 | 30.11.2021 | ||||
| Vucastar BV | 2020 | 08.03.2022 | 07.05.2022 | |||
| 2015 | 15.10.2019 | 14.12.2019 | ||||
| 2020 | 09.10.2020 | 08.12.2020 | ||||
| Karel Verlinde CommV | 2020 | 01.10.2021 | 30.11.2021 | |||
| 2020 | 04.10.2022 | 03.12.2022 | ||||
| 2020 | 04.10.2023 | 04.12.2023 | ||||
| 2015 | 15.10.2019 | 14.12.2019 | ||||
| 2020 | 09.10.2020 | 08.12.2020 | ||||
| Liesbeth Van de Velde | 2020 | 01.10.2021 | 30.11.2021 | |||
| 2020 | 04.10.2022 | 03.12.2022 | ||||
| 2020 | 04.10.2022 | 03.12.2022 | ||||
| MMW BV | 2020 | 04.10.2023 | 04.12.2023 | |||
| Céline Soto Perez | 2020 | 04.10.2022 | 03.12.2022 | |||
| Skrapa BV | 2020 | 04.10.2023 | 04.12.2023 | |||
| Marijke Goossens | 2020 | 04.10.2023 | 04.12.2023 |
Remuneration in share options
Exercise price
04.10.2033 32.25 € 0
04.10.2033 32.25 € 0
04.10.2033 32.25 € 0
04.10.2033 32.25 € 0
Options held at the beginning of
15.10.2029 23.36 € 5,000 a) n/a
09.10.2030 22.60 € 5,000 a) n/a
2023
Information with regard to the financial year under review
a) Number of optioins offered in 2023 b) Value of underlying shares on offer date
01.10.2031 28.75 € 5,000 a) n/a n/a 5,000 b) n/a
08.03.2032 32.40 € 10,000 a) n/a n/a 10,000 b) n/a
15.10.2029 23.36 € 5,000 a) n/a n/a 5,000 b) n/a
09.10.2030 22.60 € 5,000 a) n/a n/a 5,000 b) n/a
01.10.2031 28.75 € 5,000 a) n/a n/a 5,000 b) n/a
01.10.2032 32.40 € 5,000 a) n/a n/a 5,000 b) n/a
15.10.2026 23.36 € 5,000 a) n/a n/a 5,000 b) n/a
09.10.2025 22.60 € 5,000 a) n/a n/a 5,000 b) n/a
01.10.2026 28.75 € 5,000 a) n/a n/a 5,000 b) n/a
04.10.2029 32.40 € 5,000 a) n/a n/a 5,000 b) n/a
04.10.2032 32.40 € 5,000 a) n/a n/a 5,000 b) n/a
04.10.2027 32.40 € 5,000 a) n/a n/a 5,000 b) n/a
Opening balance In the course of the year (*) Closing balance
acquisition date c) Value at exercise price d) Gain on acquisition date
a) 5,000 a) 5,000
b) 161,250 € c) 161,250 €
a) 5,000 a) 5,000
b) 161,250 € c) 161,250 €
a) 5,000 a) 5,000
b) 161,250 € c) 161,250 €
a) 5,000 a) 5,000
b) 161,250 € c) 161,250 €
5,000 b) 161,250 €
5,000 b) 161,250 €
5,000 b) 161,250 €
5,000 b) 161,250 €
d) 0
d) 0
d) 0
d) 0
a) Number of acquired options b) Value of underlying shares on
n/a 5,000 b) n/a
n/a 5,000 b) n/a
Options held at the end of 2023
| Remuneration in share options | ||||||||
|---|---|---|---|---|---|---|---|---|
| Information with regard to the financial year under review | ||||||||
| Opening balance In the course of the year (*) |
Closing balance | |||||||
| 4 End of the retention period |
5 Exercise period |
6 Exercise price |
7 Options held at the beginning of 2023 |
offered in 2023 | 8 a) Number of optioins b) Value of underlying shares on offer date |
a) Number of acquired options 9 b) Value of underlying shares on acquisition date c) Value at exercise price d) Gain on acquisition date |
10 Options held at the end of 2023 |
|
| 31.12.2022 | 01.01.2023- 15.10.2029 |
23.36 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2023 | 01.01.2024- 09.10.2030 |
22.60 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2024 | 01.01.2025- 01.10.2031 |
28.75 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2026(1) | 01.01.2027- 08.03.2032 |
32.40 € | 10,000 | a) b) |
n/a n/a |
n/a | 10,000 | |
| 31.12.2022 | 01.01.2023- 15.10.2029 |
23.36 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2023 | 01.01.2024- 09.10.2030 |
22.60 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2024 | 01.01.2025- 01.10.2031 |
28.75 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2025 | 01.01.2023 01.10.2032 |
32.40 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2026 | 01.01.2027- 04.10.2033 |
32.25 € | 0 | a) b) |
5,000 161,250 € |
a) 5,000 b) 161,250 € c) 161,250 € d) 0 |
5,000 | |
| 31.12.2022 | 01.01.2023- 15.10.2026 |
23.36 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2023 | 01.01.2024- 09.10.2025 |
22.60 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2024 | 01.01.2025- 01.10.2026 |
28.75 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2025 | 01.01.2026- 04.10.2029 |
32.40 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2025 | 01.01.2026- 04.10.2032 |
32.40 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2026 | 01.01.2027- | 32.25 € | 0 | a) | 5,000 | a) 5,000 b) 161,250 € |
5,000 | |
| 04.10.2033 | b) | 161,250 € | c) 161,250 € d) 0 |
|||||
| 31.12.2025 | 01.01.2026- 04.10.2027 |
32.40 € | 5,000 | a) b) |
n/a n/a |
n/a | 5,000 | |
| 31.12.2026 | 01.01.2027- 04.10.2033 |
32.25 € | 0 | a) b) |
5,000 161,250 € |
a) 5,000 b) 161,250 € c) 161,250 € |
5,000 | |
| 31.12.2026 | 01.01.2027- | 32.25 € | 0 | a) | 5,000 | d) 0 a) 5,000 b) 161,250 € |
5,000 | |
| 04.10.2033 | b) | 161,250 € | c) 161,250 € d) 0 |
(1) Contrary to the 2020 option plan, the options are not exercisable before the end of the fourth calendar year following the year in which the options are offered.
(2) Contrary to the 2020 option plan, it was agreed that 10,000 of the options granted in 2022 remain exercisable in accordance with the normal exercise periods.
The remaining 30,000 options granted in 2022 have expired..
During 2023 no severance pay was awarded to any director or member of the executive management.
During 2023 no variable remuneration was clawed back.
During 2023, there were two departures from the remuneration policy.
It is stipulated in the remuneration policy that, in as far as a member of executive management is a management company, the total remuneration of members of executive management comprises fixed compensation, variable compensation and a share-based compensation (options).
During 2023, there were no other departures from the remuneration policy.
The highest remuneration is 5.94 times that of the lowest remuneration of a Belgian employee of the Group.
The company interprets article 3:6 §3, fifth paragraph BCC in such a way that the requirement to provide information on the changes in the remuneration, the performance of the company and the average remuneration of the employees over the past five years only applies as from 2020 and so figures from prior to 2020 are not required in the comparison. That is why the company will show that trend in the remuneration report as from 2020, but not from the years prior to 2020.
The remuneration of the members of the Board of Directors, the CEO and the members of the Management Committee and the main performance criteria evolved as follows in the period 2022-2023:
| euro | 2023 | 2022 |
|---|---|---|
| Chairman of the Board of Directors | 40,000 | 40,000 |
| Member of the Board of Directors | 20,000 | 20,000 |
| Chairman of the Audit and Risk Committee | 7,500 | 7,500 |
| Member of the Audit and Risk Committee | 5,000 | 5,000 |
| Chairman of the Nomination and Remuneration Committee |
7,500 | 7,500 |
| Member of the Nomination and Remuneration Committee |
5,000 | 5,000 |
| CEO (fixed remuneration + short-term variable remuneration) |
415,008 | 963,181 |
| Other members of the Management Committee together (fixed remuneration + short-term variable remuneration + benefits (3) |
1,448,574 | 1,834,668 |
| Comparable turnover (in million euro) | 212.1 | 211.4 |
| Comparable EBITDA (in million euro) | 56.6 | 58.0 |
(3) Insofar as the member in question is an employee.
The average remuneration of the employees in Belgium changed as follow:
| 2023 | 2022 |
|---|---|
| 3,633 | 3,458 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.